Brenyo et al., 2013 - Google Patents
QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT‐CRTBrenyo et al., 2013
- Document ID
- 8390136046082942110
- Author
- Brenyo A
- Rao M
- Barsheshet A
- Cannom D
- Quesada A
- McNITT S
- Huang D
- Moss A
- Zareba W
- Publication year
- Publication venue
- Journal of Cardiovascular Electrophysiology
External Links
Snippet
Cardiac Resynchronization Therapy and QRS Axis. Background: Mildly symptomatic heart failure (HF) patients derive substantial clinical benefit from cardiac resynchronization therapy with defibrillator (CRT‐D) as shown in MADIT‐CRT. The presence of QRS axis …
- 206010007554 Cardiac failure 0 title abstract description 39
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brenyo et al. | QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT‐CRT | |
| Linde et al. | The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual‐patient data meta‐analysis | |
| Kini et al. | Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met? | |
| Clark et al. | The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure | |
| Kadish et al. | Rationale and design for the defibrillators to reduce risk by magnetic resonance imaging evaluation (DETERMINE) trial | |
| Barsheshet et al. | Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy) | |
| Rickard et al. | The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy | |
| Goldenberg et al. | Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) | |
| Ouellet et al. | Effect of cardiac resynchronization therapy on the risk of first and recurrent ventricular tachyarrhythmic events in MADIT-CRT | |
| Cygankiewicz et al. | Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators | |
| Penn et al. | Improved outcome with preventive cardiac resynchronization therapy in the elderly: A MADIT‐CRT substudy | |
| XU et al. | Cardiac resynchronization therapy: do women benefit more than men? | |
| Ghani et al. | Predictors and long‐term outcome of super‐responders to cardiac resynchronization therapy | |
| Park et al. | Short-and long-term outcomes depending on electrical dyssynchrony markers in patients presenting with acute heart failure: clinical implication of the first-degree atrioventricular block and QRS prolongation from the Korean Heart Failure registry | |
| Sebag et al. | Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact | |
| Levy et al. | Does the implantable cardioverter-defibrillator benefit vary with the estimated proportional risk of sudden death in heart failure patients? | |
| Aktaş et al. | Survival after implantable cardioverter-defibrillator shocks | |
| Tereshchenko et al. | Antiarrhythmic effect of reverse electrical remodeling associated with cardiac resynchronization therapy | |
| Pai et al. | Prognostic significance of atrial fibrillation is a function of left ventricular ejection fraction | |
| Kanitsoraphan et al. | Baseline fragmented QRS is associated with increased all‐cause mortality in heart failure with reduced ejection fraction: A systematic review and meta‐analysis | |
| Ruwald et al. | The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) | |
| Cleland et al. | The determinants of clinical outcome and clinical response to CRT are not the same | |
| Rickard et al. | QRS fragmentation is not associated with poor response to cardiac resynchronization therapy | |
| Mehta et al. | Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk | |
| George et al. | Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy |